Pharma/biotech companies are increasingly looking to access large-scale data sets to fill gaps in their computational biology capabilities. Be prepared for the investment.
- How CGT Developers Should Think About Manufacturing Models, Hybrid Strategies, And Scale
- Enhancing Gene And Cell Therapies With Circular RNA-Based Gene Expression
- FDA Explains How To Respond To Form 483 Observations In New Draft Guidance
- Organizing Digital Systems Around Novel Modalities
- Achieving Annex 1 Compliance In Sterile Manufacturing, Part 1: Common Compliance Failures
- Hormuz Deal Brings Cautious Relief To Pharma Packaging Supply Chains
- PUPSIT In Cell & Gene Therapy: Risk Reduction Or Operational Complexity?
- Is Your AI Model Trustworthy And Credible In GMP Processes?
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![cell-therapy-GettyImages-1494029118]( "Case Study: Full Clonality Assessment Of CHO Cell Line")
Case Study: Full Clonality Assessment Of CHO Cell LineIn this case study, a comprehensive genetic analysis was performed on a transgenic Chinese hamster ovary (CHO) master cell bank to characterize the bank and provide high-confidence evidence of clonality.
-
![cdmo-rd-solution-GettyImages-2150276083]( "Why Compliance-Driven CDMOs Win Sponsor Contracts")
Why Compliance-Driven CDMOs Win Sponsor ContractsLearn how digital maturity and compliance excellence are reshaping CDMO competitiveness, as well as strategies that strengthen performance and accelerate tech transfers.
-
![GettyImages-2196950201-scientists-chromatography-system-training]( "Multi-Column Chromatography For Efficient Polishing Purification")
Multi-Column Chromatography For Efficient Polishing PurificationBoost downstream efficiency with multi-column chromatography for polishing to achieve higher productivity, reduced resin costs, and automated operation while maintaining purity and recovery.
-
![West-Vials Glamour V9]( "Long-Term Container Closure Integrity Testing Of Vial-Stopper-Seal Combinations")
Long-Term Container Closure Integrity Testing Of Vial-Stopper-Seal CombinationsThe study was designed to investigate CCI over a period of 24 months at ambient, ultra-low and cryogenic temperatures for serum-stopper samples and at ambient temperature for lyo-stopper samples.
-
![GettyImages-1388387927-computer-scans-brain-doctor-pen]( "Assessing Viability And Real-Time Apoptosis/Necrosis")
Assessing Viability And Real-Time Apoptosis/NecrosisMalignant gliomas are aggressive brain tumors that resist standard treatments. Discover why researchers focus on real-time cell death dynamics to develop targeted therapies and promising strategies.
-
![mRNA GettyImages-1356994684]( "Elevating mRNA Manufacturing Toward GMP-Readiness")
Elevating mRNA Manufacturing Toward GMP-ReadinessThe mRNA Technology Transfer Program empowers LMICs with scalable vaccine production. Learn about a partnership that drives innovation in mRNA and sets a global blueprint for equitable health access.
-
![GettyImages-2150364155-hand-digital-documents-validation]( "Mid-Sized Pharma Optimizes Local Affiliate Safety Operations")
Mid-Sized Pharma Optimizes Local Affiliate Safety OperationsManaging local affiliate PV strains any team. See how a mid-sized biopharma standardized ICSR processing across 94 countries, improved compliance tracking, and achieved centralized oversight.
-
![Cell Culture Media Filtration]( "Cell Culture Media Filtration: Evaluating Cell Culture Performance")
Cell Culture Media Filtration: Evaluating Cell Culture PerformanceCell culture performance remained consistent across PES and PVDF filters, even under worst-case filtration conditions. Discover a practical framework for evaluating membrane impact on CHO cell growth.
-
![CAR T cells-GettyImages-2243155532]( "Flexible Multiplex Solution For VCN Determination In Gamma-Retrovirus–Transduced CAR-T Cells Using QIAcuity® dPCR")
Flexible Multiplex Solution For VCN Determination In Gamma-Retrovirus–Transduced CAR-T Cells Using QIAcuity® dPCRSee how a multiplex digital PCR approach enables accurate, reproducible VCN determination in gamma‑retrovirus–transduced CAR‑T cells, supporting streamlined workflows and confident decision‑making.
-
![GettyImages-1382353763-hand-bubble-co2-green]( "Bio-Based Polymers Towards Net Zero In Single-Use Bioprocessing")
Bio-Based Polymers Towards Net Zero In Single-Use BioprocessingDecarbonizing healthcare and pharmaceuticals is vital to meet climate goals and safeguard public health. Learn why these energy-intensive sectors must act swiftly to reduce emissions and navigate complex global supply chains.
NEWSLETTER ARCHIVE
- 07.01.26 -- In Vivo Gene Editing Is Moving From Promise To Proof
- 06.30.26 -- Cell Therapy Without The Cells: Building A Therapeutic Secretome
- 06.30.26 -- Better IDS Workflows Start Here
- 06.30.26 -- PUPSIT In Cell & Gene Therapy: Risk Reduction Or Operational Complexity?
- 06.29.26 -- Simplify The Journey Of Advancing Your Therapies To Patients
- How CGT Developers Should Think About Manufacturing Models, Hybrid Strategies, And Scale
- In Vivo Gene Editing Is Moving From Promise To Proof
- Driving Gene Therapy Beyond Rare Disease Will Define The Next Era Of CGT
- CGT Manufacturing Shifts From Capacity To Strategy
- Dr. Peter Marks On Why Gene Therapy May Need A New Regulatory Playbook
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
